Johannesburg - Cipla Medpro South Africa [JSE:CMP], the drug firm being taken over by India's Cipla Medpro, said on Thursday it had promoted its two deputy chief executives to serve as joint CEOs on a temporary basis.
Skhumbuzo Ngozwana and Mark James van Lill Sardi will take over as joint acting chief executives from July 1, the company said, until a permanent chief executive is found.
They will replace acting CEO Johan du Preez.
Cipla Medpro shares were up 0.31% at R9.63 in early trade on Thursday.
Skhumbuzo Ngozwana and Mark James van Lill Sardi will take over as joint acting chief executives from July 1, the company said, until a permanent chief executive is found.
They will replace acting CEO Johan du Preez.
Cipla Medpro shares were up 0.31% at R9.63 in early trade on Thursday.